INTC
Prediction: Pivoting Away From Metaverse Will Help Meta's Stock Long Term
Shifting from the metaverse should boost Meta's profits.
Motley Fool  ·  Mar 22, 2026 READ →
NVDA
Private Space Station Companies Offer Dueling Press Releases
Congress wants NASA to pick at least two space companies to build a new International Space Station.
Motley Fool  ·  Mar 22, 2026 READ →
INTC
Private Space Station Companies Offer Dueling Press Releases
Congress wants NASA to pick at least two space companies to build a new International Space Station.
Motley Fool  ·  Mar 22, 2026 READ →
NVDA
3 Genius Artificial Intelligence (AI) Stocks You'll Regret Not Buying Now
There are several AI stocks on sale right now.
Motley Fool  ·  Mar 22, 2026 READ →
MSFT
3 Genius Artificial Intelligence (AI) Stocks You'll Regret Not Buying Now
There are several AI stocks on sale right now.
Motley Fool  ·  Mar 22, 2026 READ →
INTC
3 Genius Artificial Intelligence (AI) Stocks You'll Regret Not Buying Now
There are several AI stocks on sale right now.
Motley Fool  ·  Mar 22, 2026 READ →
AVGO
3 Genius Artificial Intelligence (AI) Stocks You'll Regret Not Buying Now
There are several AI stocks on sale right now.
Motley Fool  ·  Mar 22, 2026 READ →
GS
Beijing vows broader market access as goods trade surplus hits record levels
Investing.com -- People’s Bank of China Governor Pan Gongsheng has issued a firm defense of the nation’s ballooning trade surplus, characterized as a stabilizing force for global financial markets.
Investing.com  ·  Mar 22, 2026 READ →
NVDA
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics?
One of these assets is catalyst-driven; the other isn't.
Motley Fool  ·  Mar 22, 2026 READ →
INTC
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics?
One of these assets is catalyst-driven; the other isn't.
Motley Fool  ·  Mar 22, 2026 READ →
BTCUSDT
Got $1,500? Is It Better to Buy Bitcoin, or Viking Therapeutics?
One of these assets is catalyst-driven; the other isn't.
Motley Fool  ·  Mar 22, 2026 READ →
MRK
Merck’s New GARDASIL Data And What It May Mean For MRK Stock
Merck, NYSE:MRK, is presenting new long term data on its GARDASIL 9 and GARDASIL HPV vaccines at a major international HPV congress. The data highlight vaccine effectiveness against cancers and diseases caused by HPV, alongside updated safety findings. The disclosure includes both clinical and real world evidence on the durability of protection from Merck's GARDASIL vaccine portfolio. For investors watching NYSE:MRK, this update centers on one of Merck's key vaccine franchises rather than...
Simply Wall St.  ·  Mar 22, 2026 READ →